The AmLaw Litigation Daily highlighted Finnegan attorneys Charles Lipsey, John Livingstone, Jill MacAlpine, David Weingarten, Ryan O’Quinn, Matt Hlinka, and Megan Meyers for their District of Delaware bench trial win on behalf of client AstraZeneca. The ruling protected AstraZeneca’s FARXIGA drug products against generic competition, stating the opposition failed to prove AstraZeneca’s patent claims were invalid due to obviousness.
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Award/Ranking
World Trademark Review Recognizes Three Finnegan Partners on its 2026 Global Leaders List
June 24, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.